Introduction
Cefepime dihydrochloride drug belongs to the fourth generation of cephalosporins. 1 It has an extended spectrum of activity against gram-negative and gram-positive bacteria, with greater activity against both gram-negative and gram-positive organisms than third-generation cephalosporins. 2 It is formulated as hydrochloride salt with L-arginine added to control the pH of the reconstituted solution at 4 -6, 3 and it is used in the treatment of nosocomial pneumonia as an antibacterial agent for infections caused by Enterobacter spp., with prudent use in order to prevent the emergence of resistant organisms. 4 The molecular formula is C19H24N6O5S2·2HCl·H2O and the molecular weight is 571.5. Its IUPAC name is (6R,7R)-7-[(Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido]-3-[(1-methyl-1-pyrrolidinium)methyl]-3-cephem-4-carboxylate dihydrochloride, monohydrate. Under stress stability conditions, cephalosporins are more pronounced to cleave and produce different types of related substances. The formation of impurities during the stress studies have been studied in this work. During the preparation of Cefepime dihydrochloride in the laboratory, four known impurities were detected in HPLC, which were reported in earlier 5, 6 and in the literature. 7 In this study, a drug substance was subjected to stress conditions as per International Conference on Harmonization (ICH). The formation of two new impurities was observed during the stress conditions. An impurity profile study must be carried out for any final product, as per the regulatory requirements to identify and to characterize all unknown impurities.
The degradation products of Cefepime dihydrochloride that emerged throughout stress stability studies have been determined, identified and characterized. The two new impurities were detected by gradient reverse-phase high performance liquid chromatography (HPLC), and Impurity-I was formed in the range from 0.2 to 11.0% and Impurity-II range from 0.2 to 3.5%. These impurities have been identified by LC/MS, and were not reported in the literature. These impurities were synthesized, isolated and characterized. Based on the spectral data, the impurities were named
The structures were established unambiguously by independent synthesis and co-injection in HPLC to confirm the retention times and relative retention times. The structural elucidation of these impurities by spectral data ( 1 H NMR, 13 C NMR, 2D-NMR (COSY, HSQC and HMBC), LC/MS, TOF-MS, elemental analysis and IR), synthesis, isolation and the formation of these impurities are discussed in detail. Apparatus and methodologies High performance liquid chromatography. A Waters Alliance 2695 separation module equipped with a 2996 photodiode array detector with an Empower pro data handling system (Waters corporation, MILFORD, MA 01757, USA) was used. The analysis was carried out on an Inertsil ODS-3V, 250 mm long, 4.6 mm i.d., 5 μm particle diameter column. Mobile phase A was a mixture of phosphate buffer and acetonitrile in the ratio of 93:7 v/v, adjusted to pH 5.0 ± 0.05 with a dilute potassium hydroxide solution (phosphate buffer was prepared by dissolving 0.68 g of potassium dihydrogen orthophosphate in 1000 ml water). Mobile phase B was acetonitrile and mobile phase A was used as a diluent. UV detection was carried out at 254 nm, and the flow rate was kept at 1.0 ml/min and data acquired for 45 min. The pump mode was gradient, and the program was LC/MS. LC/MS analysis was carried out using a Perkin Elmer triple quadrupole mass spectrometer (API 2000, PE SCIEX) coupled with a Shimadzu HPLC equipped with SPD 10 AT VP UV-Vis detector and LC 10 AT VP pumps. Analyst software was used for data acquisition and data processing. The turbo ion spray voltage was maintained at 5.5 kv, and the temperature was set at 375 C. The auxiliary gas and curtain gas used was highly pure nitrogen. Zero air was used as a nebulizer gas. LC/MS spectra were acquired from m/z 100 -1000 in 0.1 amu steps with a 2.0-s dwell time. The analysis was carried out by using Inertsil ODS-3V, 150 mm long, 4.6 mm i.d., 5 μm particle diameter column. Mobile phase A consisted of 0.1% acetic acid and mobile phase B was acetonitrile. UV detection was carried out at 254 nm, and the flow rate was kept as 1.0 ml/min. The data-acquisition time was 50 min.
The 
TOF-MS.
The MS part consisted of a Micro Q-TOF spectrometer (from Waters micromass), which was operated using MassLynks (Ver. 4.1) software. The fragmentation profile of the samples was established by carrying out TOF-MS studies in a positive electrospray ionization (+ve ESI) mode. The mass parameters for TOF-MS analysis were: hexapole, Rf 0.2 V; capillary voltage, 3000 V; cone voltage, 25 V; source temperature, 120 C; desolvation temperature, 300 C; ion energy, 1.0 V; and collision energy, 8 V. The samples were directly infused using a syringe pump at a concentration of 2 mg/ml in methanol. NMR. 1D ( 1 H NMR, 13 C NMR) and 2D ( 1 H-1 H COSY, DEPT, HSQC, HMBC) NMR experiments were performed on a Bruker 300 MHz NMR spectrometer (Bruker AG Industries, Faellanden, Switzerland) using deuterated dimethylsulfoxide (DMSO-d6) as the solvent and tetramethylsilane (TMS) as an internal standard. FT-IR. FT-IR spectra were recorded as KBr pellet on a Perkin-Elmer instrument model-Spectrum one.
Stress stability studies. As per International Conference on
Harmonization, stress testing is to be carried out to identify the likely degradation products, or to elucidate the inherent stability characteristics of the active substance. 9 Susceptibility to oxidation is one of the required tests and also hydrolytic, photolytic, and thermal stressing stability are required. In this study, Cefepime dihydrochloride drug substance was subjected to the following stress conditions. Thermal stress: The drug substance was subjected to dry heat at 105 C for 88 h.
Stress study under hydrolytic conditions: acidic hydrolysis, a sample solution was mixed with a 1 M hydrochloric acid solution and exposed to 85 C for 10 min; alkaline hydrolysis, a sample solution was mixed with a 0.5 M sodium hydroxide solution and exposed as such.
Stress study under an oxidative condition: A sample solution was mixed with a 5% H2O2 solution and exposed to 85 C for 5 min.
Stress study under photolytic condition: A sample was exposed to photolytic degradation as per ICH requirement. 10 Stress study under humidity condition: A sample was exposed to degrade under 92% RH at 25 C for 138 h.
The sample solutions described under the stress stability conditions were diluted to the required concentration and injected into HPLC using the analytical conditions described above. The chromatograms show the retention times and relative retention times of the degradation products formed under various stress conditions, along with specified impurities in official monographs and one impurity reported in the literature. In the thermal-degradation condition, two unknown peaks were identified at relative retention times with respect to the Cefepime peak were 0.66 and 2.36, respectively. In the acid degradation condition, one unknown impurity was identified, which had the same relative retention time (2.36) as that observed under the thermal degradation condition. Under the peroxide degradation condition, one unknown peak was identified, which was the same relative retention time (0.66) as that observed under the thermal degradation condition. These two unknown impurities at relative retention times of around 0.66 (Impurity-I) and 2.36 (Impurity-II) showed m/z values of 497 and 370, respectively, by LC-MS analysis. These two impurities were prepared in small quantities by the preparative isolation method and co-injected into HPLC to confirm the relative retention times, and we also performed FT-IR analysis for identification purposes. Impurity-I was synthesized by a chemical process and Impurity-II was synthesized by a chemical process followed by isolation by preparative HPLC. All of the impurities were co-injected with Cefepime dihydrochloride sample in HPLC to confirm the retention times and relative retention times. The typical HPLC chromatograms of the Cefepime dihydrochloride control sample, Cefepime dihydrochloride spiked with pharmacopoeial impurities along with Impurity-I and Impurity-II and Cefepime dihydrochloride spiked with Impurity-I and Impurity-II, are shown in the Figs. 1(a), 1(b) and 1(c) , respectively. The synthesis, isolation, structural elucidation and formation of these impurities are discussed in the following sections.
Results and Discussion
Structural elucidation of impurities Impurity-I. The ESI mass spectrum of Impurity-I displayed the protonated molecular ion at m/z 497, which is 16 amu more than that of Cefepime [M+H] + ion 481, which indicates the possible incorporation of oxygen in the molecule. The LC/TOF-MS mass spectrum of Impurity-I shows the observed mass value [M+H] + ion 497.1183, which is similar to the theoretical mass for the [ The DEPT spectrum shows two methyl groups (C-6 and C-21), six methylene groups (C-12, C-16, C-17, C-18, C-19 and C-20) and three methyne groups (C-3, C-9 and C-10). After a close inspection, an evaluation was made based on the spectral data of Cefepime, and Impurity-I ( 1 H NMR, 13 C NMR, DEPT and HSQC) revealed the presence of the following functionalities: three carbonyl groups (C-7, C-11 and C-15) and five quaternary carbons (C-2, C-4, C-5, C-13 and C-14). The connection of these functional groups was determined on the basis of H-H-COSY and HMBC correlations. The cross-peak multiplets observed at (9.39 ppm, 5.97 ppm) and (5.20 ppm, 5.97 ppm) in the H-H COSY spectrum correspond to the 8th (9.39 ppm), 9th (5.97 ppm) and 10th (5.20 ppm) positions, similarly the cross peak multiplets observed at (3.44 ppm, 3.65 ppm) correspond to the two sets of 1 H each at 17th and 20th positions and at (2.1 ppm, 3.65 ppm) and (2.1 ppm, 3.44 ppm) correspond to the two sets of 1 H each at 18th and 19th positions. In 13 C NMR, the methyne carbon (C-10) has shifted downfield from 58.4 to 66.7 ppm, and the methylene carbon signal (C-12) has shifted downfield from 28.7 to 48.3 ppm in comparison with Cefepime. In 1 H NMR also, the methyne proton (C-10) has shifted slightly upfield from 5.32 ppm (J = 4.67 Hz) to 5.20 ppm (J = 4.64 Hz) and the methylene (C-12) ABq signal has shifted downfield from 3.65 and 4.03 ppm (J = 17.1 Hz) to 4.14 ppm corresponding to singlet in comparison with Cefepime, 11, 12 confirming oxygen atom addition on the cephem ring. Moreover, in FT-IR, alkyl and aryl sulfoxides should show strong absorption in the 1070 -1030 cm -1 region. 13 The FT-IR spectrum of this Impurity-I showed a strong band at 1046 cm -1 frequency, which confirmed and supported the structure of this impurity having the S=O bond. Based on these spectral data, the Impurity-I was named as 13 C NMR spectrum shows 13 carbon signals and DEPT spectra shows one methyl group (C-6), three methylene groups (C-9, C-12 and C-16) and two methyne groups (C-3 and C-10). After a close inspection, an evaluation was made based on the spectral data of Cefepime, and Impurity-II ( 1 H NMR, 13 C NMR, DEPT and HSQC) revealed the presence of following functionalities: two carbonyls (C-7 and C-15) and five quaternary carbons (C-2, C-4, C-5, C-13 and C-14).
The connection of these functional groups was determined on the basis of H-H-COSY and HMBC correlations. The cross-peak multiplets observed at (4.55 ppm, 3.45 ppm), (8.76 ppm, 3.45 ppm) and (6.01 ppm, 4.55 ppm) in the H-H COSY spectrum correspond to 9th (3.45 ppm), 10th (4.55 ppm) and 22nd (6.01 ppm) position protons. In comparison with Cefepime, a distinguishable cross peak in HMBC spectra corresponds to CH2 signal at the 16th position (4.84 ppm) correlates to the carbon signal at the 15th position (169.8 ppm). Similarly, the carbonyl carbon at the 7th position (149.6 ppm) shows a cross peak that correlates with the proton signal at the 9th position (3.45 ppm). All of these cross peaks confirm the correlations of the proposed structure. In the 1 H NMR spectrum, the most important observation was that the signals corresponding to N-methyl pyrrolidine were not seen. Moreover, we observed the methylene proton (C-9) at 3.45 ppm as a triplet instead of a methyne proton, compared with Cefepime. 11, 12 In 13 C NMR and DEPT, the spectra show the absence of N-methyl pyrrolidine carbons and β-lactam carbonyl (C-11) in comparison with Cefepime, and additionally one methylene carbon (C-16) was observed at 71.1 ppm. The FT-IR spectrum shows the absence of the β-lactam carbonyl absorption band and one lactone related carbonyl strong absorption band observed at ~1744 cm -1 . Based on the spectral data, the β-lactam ring had been decarbonized by hydrolysis, and the side chain had been eliminated and followed by lactonized. From this data and observations, Impurity-II was named as
Spectroscopic data
The chemical structures of Cefepime dihydrochloride, Impurity-I and Impurity-II are given in Figs. 2(a), 2(b) and 2(c), respectively. The 1 H and 13 C NMR chemical shift values and DEPT and HMBC assignments of Cefepime and its impurities are presented in Table 1 . A comparison between the FT-IR spectral data of the found and synthetic impurities with Cefepime is presented in Table 2 .
Synthesis of Impurity-I
Cefepime dihydrochloride sample (10 g) was dissolved in methanol (60 ml) at 25 -30 C and the resulting solution was cooled to 0 -5 C. Peracetic acid (7.97 g, 20%(w/w)) was slowly added over 40 min at 0 -10 C. Thereafter, the reaction mass was stirred at 5 -10 C for 1 h and diluted with acetone (600 ml) at 5 -15 C. The resulting crystals were collected by filtration, washed with precooled acetone under a nitrogen atmosphere and dried to afford 6.6 g of Impurity-I.
Synthesis followed by isolation of Impurity-II
A Cefepime dihydrochloride sample (100 g) was dissolved in DM water (330 ml) and cooled to 0 -5 C. Amberlite LA resin (168 ml) was dissolved in toluene (900 ml), and slowly added to the reaction mass and stirred for 45 min at this temperature. Hyflo (6 g) was added to the reaction mass and filtered, and washed with water (10 ml). A toluene layer was separated from the filtrate and extracted with water (60 ml). The combined aqueous layer was washed with toluene (2 × 200 ml). Hydrochloric acid (conc. HCl, 80 ml in 1600 ml water) was added to the aqueous solution at 25 -27 C. The temperature was raised to 40 C and stirred for 36 h at this temperature. Thereafter, we cooled the reaction mass to 30 C, and the pH was adjusted to 0.3 -0.4 with a 10%(w/v) aqueous sodium hydroxide solution (225 ml). The reaction mass was filtered and the filtrate was extracted with ethyl acetate (2 × 200 ml). An ethyl acetate layer was completely concentrated under reduced pressure at 40 C. The residue containing Impurity-II was isolated by preparative HPLC. Fractions collected were analyzed by analytical HPLC. Fractions containing Impurity-II, which were greater than 90%, were pooled together, and concentrated on a rotavapor to remove acetonitrile. The concentrated fractions were passed through the preparative column using water:acetonitrile (50:50) as mobile phase to remove the buffers used for isolation. Again the elute was concentrated in a rotavapor to remove acetonitrile. The aqueous solutions were lyophilized using a freeze dryer (Virtis Advantage 2XL).
Formation of impurities
Impurity-I originated from the oxidation of Cefepime dihydrochloride with traces of peroxides present in acetone, which was used as a solvent in the synthesis of Cefepime dihydrochloride. The formation of Impurity-I is given in Fig. 3(a) . Impurity-II was formed under acidic and thermal degradation conditions. The hydrolytic cleavage of the β-lactam ring in Cefepime dihydrochloride followed by the expulsion of the N-methylpyrrolidine resulted in the exomethylene compound, which upon decarboxylization and lactonization resulted in Impurity-II. The mechanism for the formation of Impurity-II is given in Fig. 3(b) .
Conclusion
A Cefepime dihydrochloride drug substance was subjected to stress studies, and we evaluated the degradation products. Two unknown impurities were identified, synthesized, isolated and characterized by various spectroscopic techniques like FT-IR, NMR and MS. The most probable structures are proposed for these impurities based on available spectral data.
